Navigation Links
Alba Therapeutics Corporation Announces Promotions
Date:10/2/2008

BALTIMORE, Oct. 2 /PRNewswire/ -- Alba Therapeutics Corporation today announced the promotions of Linda Arterburn, PhD, Francisco Leon, MD, PhD, Roberto Allen, Esquire, Mark Ginski, PhD, and Kate Huber. "We are pleased to announce the promotions of several of our team members and we are fortunate to have such a fine group of talented people working here to help us develop medicines for unmet medical needs of patients with celiac disease, asthma, eye disorders, and other areas to treat autoimmune and inflammatory disease," said Bruce Peacock, CEO of Alba Therapeutics.

Linda Arterburn, PhD, has been promoted to Vice President of Preclinical Development and Program Management at Alba. Prior to joining Alba, Dr. Arterburn was Executive Director of Discovery Research at Market Biosciences. In this capacity, she initiated an inflammation research program and was lead inventor on two patents involving novel anti-inflammatory lipids. She previously led Clinical Research and Scientific Affairs at Market where she played a key role in the regulatory authorizations for the addition of Market's fatty acid products, DHA and ARA, to infant formula in the United States and Canada. Dr. Arterburn also spent seven years at W.R. Grace & Co., where she led an in vitro toxicology research program, and then served as Manager of Technology and Planning. Dr. Arterburn received her PhD in Pharmacology and the Molecular Sciences from the Johns Hopkins University School of Medicine, and her Bachelor's Degree in Biochemistry from the University of Wisconsin.

Francisco Leon, MD, PhD has been promoted to Vice President, Clinical Development and Medical Affairs. Dr. Leon is an immunologist with broad training in basic and clinical Immunology and a vocation for clinical development in the field of Mucosal Immunology. Prior to joining Alba, Dr. Leon was a Director of Clinical Development, Inflammatory and Respiratory Diseases at Med Immune where he worked on asthma and mucosal
'/>"/>

SOURCE Alba Therapeutics Corporation
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related biology technology :

1. Vicus Therapeutics to Present at the 234th American Chemical Society National Meeting in Boston, MA
2. DJO Incorporateds Pending Merger With ReAble Therapeutics Clears U.S. Antitrust Review
3. PeriCor Therapeutics Announces Closing of Licensing Agreement for Acadesine with Schering-Plough Corporation
4. Systems Medicine (SM), a Subsidiary of Cell Therapeutics, Inc. (CTI), Announces Execution of CRADA with NCI/NIH to Develop Potential Cancer Treatments Targeting the Insulin Growth Factor (IGF) Pathway
5. Amsterdam Molecular Therapeutics to Release H1 2007 Results on August 29, 2007
6. Nektar Therapeutics Appoints Tim Harkness as Chief Financial Officer
7. ExonHit Therapeutics: Allergan and ExonHits First Collaboration Compound to Begin Human Clinical Trials
8. Cell Therapeutics, Inc. Takes Corrective Actions in Response to Nasdaq Determination
9. Amsterdam Molecular Therapeutics Reports Half Year Results 2007
10. Nektar Therapeutics Appoints Lutz Lingnau as New Board Member
11. Anesiva Grants Specific-Use License of Its Needle-Free Drug Delivery Technology to Particle Therapeutics for Diabetes Drug
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/20/2013)... May 20, 2013 Pacific Biomarkers and Clinigene International ... developers of biosimilars at the 2013 AAPS/ National ... Diego Hotel and Marina , ... the opportunity to speak with company representatives at their ... Cross" on May 21 from 1-2 p.m. in the ...
(Date:5/20/2013)... BALTIMORE , May 20, 2013 /PRNewswire/ ... private-public partnership focusing on commercializing market-relevant biohealth innovations ... Central Maryland , today announced its ... first Entrepreneur-in-Residence (EIR) for BHI at the National ... and Blood Institute (NHLBI). Dr. Aiyar will ...
(Date:5/20/2013)... 2013   Flexion Therapeutics , Inc. today announced ... to its management team as chief financial officer. ... management experience with biotechnology and medical device companies. ... financial officer for Novavax (NASDAQ: NVAX ) ... $250 million through a combination of investment funding and ...
(Date:5/20/2013)... May 20, 2013 Interventional cardiologist Tony ... General Hospital (AGH) Cardiovascular Institute have helped pioneer ... artery disease (CAD) over the past three decades, ... balloon angioplasty and coronary artery stent implantation. , Today, ... play a prominent role in the study of a ...
Breaking Biology Technology:Pacific Biomarkers and Clinigene International To Announce Laboratory Solutions for Developers of Biosimilars at 2013 AAPS/ National Biotechnology Conference 2BioHealth Innovation, Inc. Names Ram Aiyar as Entrepreneur-in-Residence to NIH National Heart, Lung and Blood Institute 2BioHealth Innovation, Inc. Names Ram Aiyar as Entrepreneur-in-Residence to NIH National Heart, Lung and Blood Institute 3BioHealth Innovation, Inc. Names Ram Aiyar as Entrepreneur-in-Residence to NIH National Heart, Lung and Blood Institute 4Flexion Therapeutics Names Frederick Driscoll Chief Financial Officer 2Allegheny General Hospital Cardiovascular Institute Becomes Exclusive Pittsburgh Site for Study of Novel Coronary Artery Disease Device 2Allegheny General Hospital Cardiovascular Institute Becomes Exclusive Pittsburgh Site for Study of Novel Coronary Artery Disease Device 3Allegheny General Hospital Cardiovascular Institute Becomes Exclusive Pittsburgh Site for Study of Novel Coronary Artery Disease Device 4
... a biopharmaceutical company developing novel and biosuperior protein therapeutics ... appointed James A. Wells, Ph.D., and James R. Swartz, ... Prof. Wells will serve as Chairman of the SAB. ... experts in the field of protein engineering to provide ...
... announced today that it has secured $47.5 million in ... the financing along with existing investors OrbiMed Advisors, New ... the financing, Josh Bilenker, M.D., Partner at Aisling Capital, ... this round will support commercialization of the company,s Atlas™ ...
... Colo., Jan. 6, 2012 LABS, Inc., a global, ... expertise in regulated testing for human organs, cells, tissues ... it has been granted AABB Accreditation for donor testing. ... safety of collecting, processing, testing, distributing and administering blood ...
Cached Biology Technology:Sutro Announces Newly Formed Scientific Advisory Board 2Sutro Announces Newly Formed Scientific Advisory Board 3Roka Bioscience Secures $47.5 Million in Series D Financing 2LABS, Inc. Earns AABB Accreditation for Donor Testing 2
(Date:5/17/2013)... College study finds human-caused climate change may have ... contradicting a host of recent studies that predict ... , The findings, which appear in the journal ... for survival of a creature thought to be ... tropical cold-blooded animals, especially forest lizards, will be ...
(Date:5/17/2013)... An international team of scientists using a ... movement inside a living frog embryo in greater detail ... to advance biological research and the search for new ... the Karlsruher Institut fr Technologie in Germany, in collaboration ... of Energy,s Argonne National Laboratory, released the most precise ...
(Date:5/16/2013)... to Research Careers) Program has announced the travel ... Annual Meeting in San Francisco, CA from June ... the entry of students, postdoctorates and scientists from ... science community and to encourage the participation of ... , Awards are given to poster/platform presenters and ...
Breaking Biology News(10 mins):Climate change may have little impact on tropical lizards 2New X-ray method shows how frog embryos could help thwart disease 2
... isnt the only way that carbon monoxide (CO) damages ... According to the findings of a new study, ... CO also causes direct damage to the heart muscle, ... the hearts pumping capacity and permanently impairs cardiac function. ...
... 29, 2008 A Canada-U.S. research team has found ... decline of water quality in coastal waters. In the ... Caraco explain that the collapse of the fisheries from ... in disturbing the balance between nitrogen entering and leaving ...
... a $1.8 million grant from the W.M. Keck Foundation ... and dramatic transformations that occur in processes where small-scale ... include the breakup of splashing water droplets, the sudden ... occur in a dividing cell. The University has ...
Cached Biology News:Carbon monoxide may cause long-lasting heart damage 2Bad news for coastal ocean: less fish out, means more nitrogen in 2University of Chicago launches research program in catastrophic deformation 2University of Chicago launches research program in catastrophic deformation 3
Mouse monoclonal antibody raised against a partial recombinant CHD8. NCBI Entrez Gene ID = CHD8...
... raised against a partial recombinant ... TOPORS (NP_005793, 98 a.a. ... protein with GST tag. ... NM_005802 Protein ...
Mouse monoclonal antibody raised against a partial recombinant DENR. NCBI Entrez Gene ID = DENR...
Mouse monoclonal antibody raised against a full length recombinant SNAPC5. NCBI Entrez Gene ID = SNAPC5...
Biology Products: